Trial Profile

A Double Blind, Randomized, Repeat Dose Parallel Group Study of Recombinant Human Parathyroid Hormone Analog Tablets, or Placebo Tablets, Compared to Open Label Forsteo in Postmenopausal Women With Osteoporosis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 30 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Mar 2013 This study was the subject of an oral presentation at the 2012 Annual Meeting of the American Society of Bone and Mineral Research (ASBMR), according to a Unigene Laboratories media release.
01 Mar 2013 Results published in Bone.
12 Dec 2012 Full results have been published in BONE, the official Journal of the International Bone and Mineral Society, according to a Unigene media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com